Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Marie-France Pichon"'
Autor:
Marie-France Pichon, Jacques Rouëssé, Marie-Anne Collignon, Carine Corone, Fabrice Gutman, Alain-Paul Pecking, Jean-Louis Alberini, Myriam Wartski
Publikováno v:
Bulletin de l'Académie Nationale de Médecine. 189:963-978
RESUME La Tomographie par Emission de Positons (TEP) est une technique d’imagerie scintigraphique metabolique. Elle necessite l’administration d’un traceur marque par un isotope emetteur de positons et l’utilisation d’un appareil dedie a ce
Autor:
S. Guepratte, W. Carney, Rainer Neumann, Marc Labroquere, A. Bethune-Volters, Marie-France Pichon, Kamel Hacene
Publikováno v:
Immuno-analyse & Biologie Spécialisée. 19:250-254
Resume L’oncogene HER-2/neu code un recepteur membranaire, la proteine p185 qui constitue un facteur pronostique pejoratif dans le cancer du sein. Le statut HER-2 de la tumeur permet de guider le traitement par trastuzumab (Herceptin®), un anticor
Autor:
Alain Ravaud, Gael Deplanque, Xavier Muracciole, François Goldwasser, Jean Michel Vannetzel, Eric Voog, Corine Teghom, Stéphane Culine, Yann Vano, Jean-Pascal Machiels, Philippe Beuzeboc, Annick Vieillefond, Stéphane Oudard, Thierry Nguyen, Christine Theodore, Jacques-Olivier Bay, Reza Elaidi, Gwenaelle Gravis, Franck Priou, François Radvanyi, Eugeniu Banu, Marie-France Pichon
Publikováno v:
European journal of cancer (Oxford, England : 1990). 51(1)
AIM: To investigate the efficacy and safety of gemcitabine and platinum salt, with or without trastuzumab, in patients with locally advanced or metastatic urothelial carcinoma overexpressing Her2. METHODS: The main eligibility criterion was Her2 over
Autor:
Gérard Benoit, Annick Viellefond, Pascal Blanchet, Marie-France Pichon, Stéphane Droupy, Valérie Paradis, Alain Jardin, Pascal Eschwege
Publikováno v:
European Urology. 40:169-175
We studied a series of superficial transitional cell carcinoma of the bladder to assess whether the Ki-67 labeling index predicts recurrence and progression in a cohort of patients treated by transurethral resection alone or receiving adjuvant intrav
Autor:
Marie France Pichon, Edwin Milgrom
Publikováno v:
Critical Reviews in Oncology/Hematology. 15:13-21
A third of breast cancers are estrogen dependent and respond to endocrine therapy. The estrogen receptor (ER) was the first marker used to predict the responses to treatment, and two-thirds of ER positive tumors show a favourable response. Several es
Autor:
Nicole Eche, Natacha Charlier-Bret, Jean-Marc Riedinger, Gaëlle Le Brun, Marie-France Pichon, Yvonne Fulla, Jean-Pierre Basuyau, Kamel Hacene
Publikováno v:
Clinical chemistry and laboratory medicine. 47(8)
Quality control results for serum MUC-1/CA 15-3 assays have always shown large discrepancies.This multicentre study of 15 methods (labelled M1-M15) measured coded sera from 35 patients with breast cancer without recurrence (group 1), 46 patients at 1
Autor:
Jean‐Pierre Lotz, Marie-France Pichon, Monica Fornier, Diana Lüftner, Suhail M. Ali, Francisco J. Esteva, Allan Lipton, Lyndsay Harris, Walter P. Carney, Wolfgang J. Köstler
Publikováno v:
Cancer. 113(6)
BACKGROUND. Previous reports based on small patient numbers suggested that changes in serum HER-2/neu levels may predict response or lack of response to trastuzumab-based therapies in metastatic breast cancer (MBC). The objectives of this study were
Publikováno v:
Anticancer research. 26(3B)
Soluble Fas (sFas) and cytokeratin 18-Asp396 neoepitope (CK18-NE) were measured by ELISA in serial samples from 42 patients with different cancers under chemotherapy and were compared with pharmacokinetic results. Baseline sFas (median 6146 pg/ml, ra
Autor:
Jacques, Rouëssé, Jean-Louis, Alberini, Myriam, Wartski, Fabrice, Gutman, Marie-Anne, Collignon, Carine, Corone, Marie-France, Pichon, Alain-Paul, Pecking
Publikováno v:
Bulletin de l'Academie nationale de medecine. 189(5)
Positron emission tomography (PET) is a metabolic radionuclide imaging method in which a tracer labeled with a positron emitter is detected with a dedicated system. 18F-fluorodeoxyglucose (FDG) accumulates in tumor cells because of their increased gl
Publikováno v:
Cancer letters. 235(1)
In contrast to the long-held belief that breast cancer is a weakly immunogenic tumor, accumulating evidence indicates an immune infiltrate is an invariable finding in breast cancers, raising hopes that immunotherapy for breast cancers may succeed in